Zoetis Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 59 rows in 2026. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2026-06-17: Reporting owner Nayak Abhay U; Form 3; Security Stock Option; Transaction Holding.
- 2026-06-17: Reporting owner Nayak Abhay U; Form 3; Security Stock Option; Transaction Holding.
- 2026-06-17: Reporting owner Nayak Abhay U; Form 3; Security Stock Option; Transaction Holding.
- 2026-06-17: Reporting owner Nayak Abhay U; Form 3; Security Stock Option; Transaction Holding.
ZTS insiders transactions against the stock price
Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close
Logarithmic scale. Both lines share the same starting value for the selected range.
Markers: each transaction type positioned at that session's split-adjusted close. Tooltips retain the reported transaction price when available.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-17 holding as of filing | Nayak Abhay U Officer (Executive Vice President) | 3 | Stock Option Derivative · Direct | Holding | $129.13 exercise price | 2026-06-17 | ||
| 2026-06-17 holding as of filing | Nayak Abhay U Officer (Executive Vice President) | 3 | Stock Option Derivative · Direct | Holding | $156.64 exercise price | 2026-06-17 | ||
| 2026-06-17 holding as of filing | Nayak Abhay U Officer (Executive Vice President) | 3 | Stock Option Derivative · Direct | Holding | $196.14 exercise price | 2026-06-17 | ||
| 2026-06-17 holding as of filing | Nayak Abhay U Officer (Executive Vice President) | 3 | Stock Option Derivative · Direct | Holding | $162.07 exercise price | 2026-06-17 | ||
| 2026-06-17 holding as of filing | Nayak Abhay U Officer (Executive Vice President) | 3 | Stock Option Derivative · Direct | Holding | no price filed | 2026-06-17 | ||
| 2026-02-19 holding as of filing | Esch Kevin Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 1,181 owned after | $156.64 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | Esch Kevin Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 490 owned after | $196.14 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | Esch Kevin Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 545 owned after | $162.07 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | Esch Kevin Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 391 owned after | $201.30 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | Ferran Astorga Jeannette Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 4,973 owned after | $156.64 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | Ferran Astorga Jeannette Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 2,328 owned after | $196.14 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | Ferran Astorga Jeannette Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 2,353 owned after | $162.07 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | Ferran Astorga Jeannette Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 4,057 owned after | no price filed | 2026-02-19 | |
| 2026-02-19 holding as of filing | Sarbaugh Keith Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 4,453 owned after | $156.64 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | Sarbaugh Keith Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 1,348 owned after | $196.14 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | Sarbaugh Keith Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 3,142 owned after | $166.44 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | FULLER JULIE Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 8,642 owned after | $156.64 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | Lagano Roxanne Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 8,642 owned after | $156.64 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | Lagano Roxanne Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 6,127 owned after | $196.14 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | Lagano Roxanne Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 6,542 owned after | $162.07 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | Lagano Roxanne Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 20,221 owned after | no price filed | 2026-02-19 | |
| 2026-02-19 holding as of filing | Driscoll Rimma Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 5,235 owned after | $156.64 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | Driscoll Rimma Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 2,500 owned after | $196.14 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | Driscoll Rimma Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 2,077 owned after | $162.07 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | Driscoll Rimma Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 5,271 owned after | no price filed | 2026-02-19 | |
| 2026-02-19 holding as of filing | PECK KRISTIN C Director, Officer (Chief Executive Officer) | 4 | Stock Option Derivative · Direct | Holding | 84,711 owned after | $156.64 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | PECK KRISTIN C Director, Officer (Chief Executive Officer) | 4 | Stock Option Derivative · Direct | Holding | 62,500 owned after | $196.14 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | PECK KRISTIN C Director, Officer (Chief Executive Officer) | 4 | Stock Option Derivative · Direct | Holding | 67,148 owned after | $162.07 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | PECK KRISTIN C Director, Officer (Chief Executive Officer) | 4 | Stock Option Derivative · Direct | Holding | 249,632 owned after | no price filed | 2026-02-19 | |
| 2026-02-19 holding as of filing | Ashton Nicholas Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 8,642 owned after | $156.64 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | Ashton Nicholas Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 4,289 owned after | $196.14 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | Ashton Nicholas Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 4,304 owned after | $162.07 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | Ashton Nicholas Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 3,369 owned after | no price filed | 2026-02-19 | |
| 2026-02-19 holding as of filing | Brannan Jamie Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 13,877 owned after | $156.64 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | Brannan Jamie Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 5,955 owned after | $196.14 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | Brannan Jamie Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 4,103 owned after | $162.07 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | Brannan Jamie Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | Holding | 6,941 owned after | no price filed | 2026-02-19 | |
| 2026-02-19 holding as of filing | Joseph Wetteny Officer (Chief Financial Officer) | 4 | Stock Option Derivative · Direct | Holding | 23,625 owned after | $156.64 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | Joseph Wetteny Officer (Chief Financial Officer) | 4 | Stock Option Derivative · Direct | Holding | 15,625 owned after | $196.14 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | Joseph Wetteny Officer (Chief Financial Officer) | 4 | Stock Option Derivative · Direct | Holding | 15,208 owned after | $162.07 exercise price | 2026-02-19 | |
| 2026-02-19 holding as of filing | Joseph Wetteny Officer (Chief Financial Officer) | 4 | Stock Option Derivative · Direct | Holding | 11,243 owned after | $201.30 exercise price | 2026-02-19 | |
| 2026-02-18 | Esch Kevin Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,931 15,931 owned after | $129.13 exercise price | $129.13 | 2026-02-19 |
| 2026-02-18 | Ferran Astorga Jeannette Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,693 8,693 owned after | $129.13 exercise price | $129.13 | 2026-02-19 |
| 2026-02-18 | Sarbaugh Keith Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,581 10,581 owned after | $129.13 exercise price | $129.13 | 2026-02-19 |
| 2026-02-18 | FULLER JULIE Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,345 14,345 owned after | $129.13 exercise price | $129.13 | 2026-02-19 |
| 2026-02-18 | Lagano Roxanne Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +14,499 14,499 owned after | $129.13 exercise price | $129.13 | 2026-02-19 |
| 2026-02-18 | Driscoll Rimma Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,191 9,191 owned after | $129.13 exercise price | $129.13 | 2026-02-19 |
| 2026-02-18 | PECK KRISTIN C Director, Officer (Chief Executive Officer) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +111,060 111,060 owned after | $129.13 exercise price | $129.13 | 2026-02-19 |
| 2026-02-18 | Ashton Nicholas Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,413 16,413 owned after | $129.13 exercise price | $129.13 | 2026-02-19 |
| 2026-02-18 | Brannan Jamie Officer (Executive Vice President) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +21,361 21,361 owned after | $129.13 exercise price | $129.13 | 2026-02-19 |
| 2026-02-18 | Joseph Wetteny Officer (Chief Financial Officer) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +34,045 34,045 owned after | $129.13 exercise price | $129.13 | 2026-02-19 |
| 2026-02-17 | PECK KRISTIN C Director, Officer (Chief Executive Officer) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 249,632 owned after | $0.00 | $125.56 | 2026-02-17 |
| 2026-02-17 holding as of filing | PECK KRISTIN C Director, Officer (Chief Executive Officer) | 4 | Stock Option Derivative · Direct | Holding | 84,711 owned after | $156.64 exercise price | 2026-02-17 | |
| 2026-02-17 holding as of filing | PECK KRISTIN C Director, Officer (Chief Executive Officer) | 4 | Stock Option Derivative · Direct | Holding | 62,500 owned after | $196.14 exercise price | 2026-02-17 | |
| 2026-02-17 holding as of filing | PECK KRISTIN C Director, Officer (Chief Executive Officer) | 4 | Stock Option Derivative · Direct | Holding | 67,148 owned after | $162.07 exercise price | 2026-02-17 | |
| 2026-01-09 holding as of filing | Esch Kevin Officer (Executive Vice President) | 3 | Stock Option Derivative · Direct | Holding | $156.64 exercise price | 2026-01-09 | ||
| 2026-01-09 holding as of filing | Esch Kevin Officer (Executive Vice President) | 3 | Stock Option Derivative · Direct | Holding | $196.14 exercise price | 2026-01-09 | ||
| 2026-01-09 holding as of filing | Esch Kevin Officer (Executive Vice President) | 3 | Stock Option Derivative · Direct | Holding | $162.07 exercise price | 2026-01-09 | ||
| 2026-01-09 holding as of filing | Esch Kevin Officer (Executive Vice President) | 3 | Stock Option Derivative · Direct | Holding | $201.30 exercise price | 2026-01-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |